LNTH News and Press, Lantheus Holdings Inc. From 11/22/21

PYLARIFY is the first and only commercially available, FDA-approved PSMA-targeted PET imaging agent for prostate cancer NORTH BILLERICA, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully i...

NORTH BILLERICA, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to fin...

NORTH BILLERICA, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to find, fight and fo...

Lantheus Holdings, Inc. (LNTH) Q3 2021 Earnings Conference Call November 04, 2021 8:00 AM ET Company Participants Mark Kinarney - Senior Director of IR Mary Anne Heino - President and CEO Paul Blanchfield - Chief Commercial Officer Robert Marshall - CFO and Treasurer Conference Call Participa...

Lantheus Holdings Inc. (NASDAQ:LNTH) traded at a new 52-week high today of $29.26. So far today approximately 371,000 shares have been exchanged, as compared to an average 30-day volume of 342,000 shares. Lantheus Holdings Inc caters to the United States healthcare sector with the develo...

The following slide deck was published by Lantheus Holdings, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Lantheus Holdings, Inc. 2021 Q3 - Results - Earnings Call Presentation

Lantheus Holdings (LNTH +13.5%) shares have reached a four-month high in morning hours despite lower than expected earnings posted by the company for Q3 2021. However, its updated outlook has exceeded the Street forecasts, The North Billerica, Massachusetts-based healthcare supplier has ...

Lantheus (NASDAQ:LNTH): Q3 Non-GAAP EPS of -$0.08 misses by $0.14; GAAP EPS of -$0.20 misses by $0.18. Revenue of $102.07M (+15.3% Y/Y) beats by $4.94M. Press Release For further details see: Lantheus EPS misses by $0.14, beats on revenue

Worldwide revenue of $102.1 million for the third quarter 2021, representing an increase of 15.3% from the prior year period GAAP net loss of $13.4 million for the third quarter 2021, compared to GAAP net loss of $6.4 million in the prior year period GAAP fully d...

Lantheus (NASDAQ:LNTH) is scheduled to announce Q3 earnings results on Thursday, November 4th, before market open. The consensus EPS Estimate is $0.06 (+50.0% Y/Y) and the consensus Revenue Estimate is $97.13M (+9.7% Y/Y). Over the last 2 years, LNTH has beaten EPS estimates 100% of the time ...